Ka. Green et al., EVIDENCE FOR A CONTINUED REQUIREMENT FOR CD40 CD40 LIGAND (CD154) INTERACTIONS IN THE PROGRESSION OF LP-BM5 RETROVIRUS-INDUCED MURINE AIDS/, Virology, 241(2), 1998, pp. 260-268
In genetically susceptible C57BL/6 mice the LP-BM5 isolate of murine r
etroviruses causes profound splenomegaly, lymphadenopathy, hypergammag
lobulinemia, and an immunodeficiency syndrome bearing many similaritie
s to the pathologies seen in AIDS. Because of these similarities, whic
h also include terminal B cell lymphoma formation, this syndrome has b
een called murine AIDS or MAIDS. Prompted by previous reports showing
that the onset of MAIDS is dependent on the presence of both CD4(+) T
and B cells, we have previously shown that anti-gp39/CD40 ligand mAb (
anti-CD40L mAb) treatment of LP-BM5-infected mice is effective in inhi
biting the induction of MAIDS when a short course of anti-CD40L mAb tr
eatment was started on the same day as LP-BM5 administration. The succ
ess of anti-CD40L mAb therapy, as indicated by a much reduced degree o
f splenomegaly, hypergammaglobulinemia, and mitogen and allogeneic CTL
unresponsiveness, demonstrated that CD40L/CD40 interactions were crit
ical to the establishment of MAIDS. Here we extend these findings thro
ugh the use of delayed anti-CD40L mAb treatment of mice, beginning 3-4
weeks after LP-BM5 infection, by showing that interruption of CD40L/C
D40 interactions also interferes with the progression of MAIDS. About
60% of LP-BM5-preinfected mice were affected by delayed anti-CD40L mAb
treatment, with substantially reduced spleen weights and serum hyperg
ammaglobulinemia and normal or greatly restored proliferative response
s to Con A stimulation and CTL responses to allogeneic stimulation. Th
e other LP-BM5-infected mice that did not respond to anti-CD40L therap
y were found to have made antibodies to the anti-CD40L mAb. Thus, in a
majority of mice anti-CD40L mAb therapy was very effective in interfe
ring with MAIDS pathogenesis well after the establishment of the virus
infection and MAIDS symptomatology, indicating that CD40L/CD40 intera
ctions are crucial to the maintenance and progression of the disease,
as well as its initiation. (C) 1998 Academic Press.